A first in human study of SB-743921, a kinesin spindle protein inhibitor, to determine pharmacokinetics, biologic effects and establish a recommended phase II dose
Titel:
A first in human study of SB-743921, a kinesin spindle protein inhibitor, to determine pharmacokinetics, biologic effects and establish a recommended phase II dose
Auteur:
Holen, Kyle D. Belani, Chandra P. Wilding, George Ramalingam, Suresh Volkman, Jennifer L. Ramanathan, Ramesh K. Vasist, Lakshmi S. Bowen, Carolyn J. Hodge, Jeffrey P. Dar, Mohammed M. Ho, Peter T. C.